한글목차

세계 유전자 전달 기술 시장은 2018년 21억 5,964만 달러로 평가되었으며, 2023년까지 연평균 8.0% 이상 성장할 것으로 예상됩니다.

연구 개발 투자 증가

실적 기간 동안 유전자 전달 기술 시장은 주로 R&D 투자 확대에 의해 주도되었습니다. 연구개발(R&D)에 대한 투자는 기술 발전, 국제 경쟁, 시장 수요, 규제 압력, 세계 이슈, 자본 접근성, 장기적인 성장과 경쟁의 주요 촉진제로서의 연구개발에 대한 인식 등으로 인해 증가하고 있습니다. 이러한 투자는 새로운 전달 시스템 개발, 표적화 능력 향상, 안전성 프로파일 개선, 적용 범위 확대 등을 통해 유전자 전달 기술에 도움이 되고 있으며, 궁극적으로 유전성 질환 및 암과 같은 다양한 질병에 대한 보다 효과적이고 맞춤화된 치료로 이어질 수 있습니다. 예를 들어, 미국 정부 기관인 National Center for Science and Engineering Statistics에 따르면, 2022년 주 정부 기관은 연구 및 실험 개발(R&D)에 총 26억 4,400만 달러를 지출한 것으로 보고했습니다. 이는 전년도 25억 1,300만 달러에서 5.2% 증가한 수치입니다. 따라서 연구개발에 대한 투자 확대는 유전자 전달 기술 시장의 성장에 기여했습니다.

목차

제1장 주요 요약

• 유전자 전달 기술 - 시장 매력과 거시경제 상황

제2장 목차

제3장 목차

제4장 표목차

제5장 보고서 구조

제6장 시장 특징

• 일반적인 시장 정의
• 개요
• 유전자 전달 기술 시장 정의와 세분화
• 시장 세분화 : 모드별
  • 생물학적
  • 화학적
  • 물리적
• 시장 세분화 : 방법별
  • 생체외
  • In vivo
  • In vitro
• 시장 세분화 : 용도별
  • 유전자 치료
  • 세포 치료
  • 백신
  • 연구

제7장 주요 시장 동향

• 유전자 편집 기술을 향상시키는 혁신적인 진보
• 겸상적혈구증에 대한 획기적인 유전자 치료 승인 : Casgevy의 혁명적인 영향
• 유전자 전달 기술 진보를 촉진하는 전략적 투자
• 유전자 치료 촉진을 위한 제휴와 인수 증가

제8장 유전자 전달 기술 시장 - 거시경제 시나리오

• COVID-19의 영향 유전자 전달 기술 시장
• 우크라이나 전쟁의 영향, 유전자 전달 기술 시장
• 고인플레이션의 영향 유전자 전달 기술 시장

제9장 세계의 시장 규모와 성장

• 시장 규모
• 시장 성장 실적, 2018-2023년
  • 시장 성장 촉진요인, 2018-2023년
  • 시장 성장 억제요인, 2018-2023년
• 예측 시장 성장, 2023-2028년, 2033년
  • 시장 성장 촉진요인, 2023-2028년
  • 시장 성장 억제요인, 2023-2028년

제10장 세계의 유전자 전달 기술 시장 : 세분화

• 세계의 유전자 전달 기술 시장 : 모드별, 실적과 예측, 2018-2023년, 2028년, 2033년
• 세계의 유전자 전달 기술 시장 : 방법별, 실적과 예측, 2018-2023년, 2028년, 2033년
• 세계의 유전자 전달 기술 시장 : 용도별, 실적과 예측, 2018-2023년, 2028년, 2033년

제11장 유전자 전달 기술 시장 : 지역·국가별 분석

• 세계의 유전자 전달 기술 시장 : 지역별, 실적과 예측, 2018-2023년, 2028년, 2033년
• 세계의 유전자 전달 기술 시장 : 국가별, 실적과 예측, 2018-2023년, 2028년, 2033년

제12장 아시아태평양 시장

제13장 서유럽 시장

제14장 동유럽 시장

제15장 북미 시장

제16장 남미 시장

제17장 중동 시장

제18장 아프리카 시장

제19장 경쟁 상황과 기업 개요

• 기업 개요
• Horizon Discovery Group Co
• Bio-Rad Laboratories, Inc.
• Promega Corporation
• OriGene Technologies Inc.
• Takara Bio Inc.

제20장 경쟁 벤치마킹

제21장 경쟁 대시보드

제22장 주요 인수합병

• Tectonic Therapeutic Merged With AVROBIO
• Kyowa Kirin Acquired Orchard Therapeutics
• Syncona Acquired Applied Genetic Technologies Corp.
• Eli Lilly Acquired Akouos
• Eli Lilly Acquired Prevail Therapeutics

제23장 기회와 전략

• 세계의 유전자 전달 기술 시장, 2028년 : 신규사업 기회가 많은 나라
• 세계의 유전자 전달 기술 시장, 2028년 : 신규사업 기회가 많은 부문
• 세계의 유전자 전달 기술 시장, 2028년 : 성장 전략
  • 시장 동향 다른 전략
  • 경쟁 전략

제24장 유전자 전달 기술 시장 : 결론과 제안

• 결론
• 추천사항
  • 제품
  • 장소
  • 가격
  • 프로모션
  • 인재

제25장 부록

영문목차

Gene delivery technologies encompass a diverse range of methods utilized to introduce genetic material into target cells or organisms for various applications, including gene therapy, genetic engineering and research purposes. These technologies are crucial for manipulating genetic information, enabling the delivery of therapeutic genes, gene editing tools or genetic constructs into cells to modulate gene expression or correct genetic defects.

The gene delivery technologies market consists of revenues earned by entities (organizations, sole traders or partnerships) primarily engaged in the development, production and distribution of techniques and systems for delivering genetic material. These technologies find extensive applications in biopharmaceuticals, agriculture, research and other fields.

The global gene delivery technologies market was valued at $2,159.64 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 8.0%.

Growing Investments In Research And Development

During the historic period, the gene delivery technologies market was mainly driven by the growing investments in research and development. The investment in research and development (R&D) is growing due to technological advancements, global competition, market demand, regulatory pressures, global challenges, access to capital and the recognition of R&D as a key driver of long-term growth and competitiveness. This investment helps gene delivery technologies by enabling the development of new and improved delivery systems, enhancing targeting capabilities, improving safety profiles and expanding the range of applications, ultimately leading to more effective and personalized treatments for various diseases, including genetic disorders and cancer. For instance, according to the National Center for Science and Engineering Statistics, a US-based government agency, in 2022, state government agencies reported a total expenditure of $2.644 billion on research and experimental development (R&D). This represents a 5.2% increase from the previous year's expenditures of $2.513 billion. Therefore, growing investments in research and development contributed to the growth of the gene delivery technologies market.

Innovative Advancements To Improve Gene-Editing Technologies

Companies in the gene delivery technologies market are developing innovative products such as QIAprep& CRISPR Kit to provide rapid and sensitive characterization of clustered regularly interspaced short palindromic repeats (CRISPR)-based genome editing events in mouse or rat cells. The QIAprep& CRISPR Kit offers a streamlined workflow that includes liquid-based sample preparation, custom primer design, amplification of the region of interest and quantification of editing efficiency. For instance, in June 2021, Qiagen, a Germany-based genomics company, launched QIAprep& CRISPR Kit. This launch by QIAGEN represents a significant advancement in gene-editing technologies, providing researchers with efficient tools for analyzing and characterizing gene-editing events with high precision and sensitivity.

The global gene delivery technologies market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up to 67.3% of the total market in 2022.

Gene Delivery Technologies Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global gene delivery technologies market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for gene delivery technologies market? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The gene delivery technologies market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider gene delivery technologies market; and compares it with other markets.

The report covers the following chapters

• Introduction And Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by mode, by method and by application.
• Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the gene delivery technologies market.
• Global Market Size and Growth - Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis - Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.

Market Segmentation - Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by mode, by method and by application in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.

• Regional Market Size And Growth - Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
• Competitive Dashboard - Briefs on competitive dashboard of major players.
• Key Mergers And Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for gene delivery technologies providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

• 1) By Mode: Biological; Chemical; Physical
• 2) By Application: Gene Therapy; Cell Therapy; Vaccines; Research
• 3) By Method: Ex Vivo; In Vivo; In Vitro
• Companies Mentioned: Horizon Discovery Group Co; Bio-Rad Laboratories Inc.; Promega Corporation; OriGene Technologies Inc.; Takara Bio Inc.
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; Canada; France; Germany; UK; Italy; Spain; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; gene delivery technologies indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Gene Delivery Technologies - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Gene Delivery Technologies Market Definition And Segmentations
• 6.4 Market Segmentation By Mode
  • 6.4.1 Biological
  • 6.4.2 Chemical
  • 6.4.3 Physical
• 6.5 Market Segmentation By Method
  • 6.5.1 Ex Vivo
  • 6.5.2 In Vivo
  • 6.5.3 In Vitro
• 6.6 Market Segmentation By Application
  • 6.6.1 Gene Therapy
  • 6.6.2 Cell Therapy
  • 6.6.3 Vaccines
  • 6.6.4 Research

7 Major Market Trends

• 7.1 Innovative Advancements To Improve Gene-Editing Technologies
• 7.2 Breakthrough Gene Therapy Approval For Sickle Cell Disease: Casgevy's Revolutionary Impact
• 7.3 Strategic Investments Fueling Advancements In Gene Delivery Technologies
• 7.4 Increasing Partnerships And Acquisitions For Promoting Gene Therapy

8 Gene Delivery Technologies Market - Macro-Economic Scenario

• 8.1 COVID-19 Impact On The Gene Delivery Technologies Market
• 8.2 Impact Of The War In Ukraine On The Gene Delivery Technologies Market
• 8.3 Impact Of High Inflation On The Gene Delivery Technologies Market

9 Global Market Size and Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
  • 9.2.1 Market Drivers 2018 - 2023
  • 9.2.2 Market Restraints 2018 - 2023
• 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
  • 9.3.1 Market Drivers 2023 - 2028
  • 9.3.2 Market Restraints 2023 - 2028

10 Global Gene Delivery Technologies Market Segmentation

• 10.1 Global Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.2 Global Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.3 Global Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Gene Delivery Technologies Market, Regional and Country Analysis

• 11.1 Global Gene Delivery Technologies Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.2 Global Gene Delivery Technologies Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
  • 12.1.1 Market Overview
  • 12.1.2 Region Information
  • 12.1.3 Market Information
  • 12.1.4 Background Information
  • 12.1.5 Government Initiatives
  • 12.1.6 Regulations
  • 12.1.7 Regulatory Bodies
  • 12.1.8 Major Associations
  • 12.1.9 Taxes Levied
  • 12.1.10 Corporate Tax Structure
  • 12.1.11 Investments
  • 12.1.12 Major Companies
• 12.2 Asia-Pacific Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.3 Asia-Pacific Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.4 Asia-Pacific Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.5 Asia-Pacific Gene Delivery Technologies Market: Country Analysis
• 12.6 China Market
• 12.7 Summary
  • 12.7.1 Market Overview
  • 12.7.2 Country Information
  • 12.7.3 Market Information
  • 12.7.4 Background Information
  • 12.7.5 Government Initiatives
  • 12.7.6 Regulations
  • 12.7.7 Regulatory Bodies
  • 12.7.8 Major Associations
  • 12.7.9 Taxes Levied
  • 12.7.10 Corporate Tax Structure
  • 12.7.11 Investments
  • 12.7.12 Major Companies
• 12.8 China Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.9 China Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.10 China Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.11 India Market
• 12.12 India Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.13 India Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.14 India Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.15 Japan Market
• 12.16 Japan Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.17 Japan Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.18 Japan Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.19 Australia Market
• 12.20 Australia Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.21 Australia Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.22 Australia Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.23 Indonesia Market
• 12.24 Indonesia Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.25 Indonesia Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.26 Indonesia Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.27 South Korea Market
• 12.28 South Korea Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.29 South Korea Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.30 South Korea Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
  • 13.1.1 Market Overview
  • 13.1.2 Region Information
  • 13.1.3 Market Information
  • 13.1.4 Background Information
  • 13.1.5 Government Initiatives
  • 13.1.6 Regulations
  • 13.1.7 Regulatory Bodies
  • 13.1.8 Major Associations
  • 13.1.9 Taxes Levied
  • 13.1.10 Corporate tax structure
  • 13.1.11 Investments
  • 13.1.12 Major Companies
• 13.2 Western Europe Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.3 Western Europe Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.4 Western Europe Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.5 Western Europe Gene Delivery Technologies Market: Country Analysis
• 13.6 UK Market
• 13.7 UK Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.8 UK Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.9 UK Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.10 Germany Market
• 13.11 Germany Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.12 Germany Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.13 Germany Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.14 France Market
• 13.15 France Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.16 France Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.17 France Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.18 Italy Market
• 13.19 Italy Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.20 Italy Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.21 Italy Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.22 Spain Market
• 13.23 Spain Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.24 Spain Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.25 Spain Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
  • 14.1.1 Market Overview
  • 14.1.2 Region Information
  • 14.1.3 Market Information
  • 14.1.4 Background Information
  • 14.1.5 Government Initiatives
  • 14.1.6 Regulations
  • 14.1.7 Regulatory Bodies
  • 14.1.8 Major Associations
  • 14.1.9 Taxes Levied
  • 14.1.10 Corporate Tax Structure
  • 14.1.11 Major Companies
• 14.2 Eastern Europe Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.3 Eastern Europe Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.4 Eastern Europe Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.5 Eastern Europe Gene Delivery Technologies Market: Country Analysis
• 14.6 Russia Market
• 14.7 Russia Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.8 Russia Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.9 Russia Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

• 15.1 Summary
  • 15.1.1 Market Overview
  • 15.1.2 Region Information
  • 15.1.3 Market Information
  • 15.1.4 Background Information
  • 15.1.5 Government Initiatives
  • 15.1.6 Regulations
  • 15.1.7 Regulatory Bodies
  • 15.1.8 Major Associations
  • 15.1.9 Taxes Levied
  • 15.1.10 Corporate Tax Structure
  • 15.1.11 Investments
  • 15.1.12 Major Companies
• 15.2 North America Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.3 North America Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.4 North America Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.5 North America Gene Delivery Technologies Market: Country Analysis
• 15.6 USA Market
• 15.7 Summary
  • 15.7.1 Market Overview
  • 15.7.2 Country Information
  • 15.7.3 Market Information
  • 15.7.4 Background Information
  • 15.7.5 Government Initiatives
  • 15.7.6 Regulations
  • 15.7.7 Regulatory Bodies
  • 15.7.8 Major Associations
  • 15.7.9 Taxes Levied
  • 15.7.10 Corporate Tax Structure
  • 15.7.11 Investments
  • 15.7.12 Major Companies
• 15.8 USA Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.9 USA Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.10 USA Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.11 Canada Market
• 15.12 Canada Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.13 Canada Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.14 Canada Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

• 16.1 Summary
  • 16.1.1 Market Overview
  • 16.1.2 Region Information
  • 16.1.3 Market Information
  • 16.1.4 Background Information
  • 16.1.5 Government Initiatives
  • 16.1.6 Regulations
  • 16.1.7 Regulatory Bodies
  • 16.1.8 Major Associations
  • 16.1.9 Taxes Levied
  • 16.1.10 Corporate Tax Structure
  • 16.1.11 Investments
  • 16.1.12 Major Companies
• 16.2 South America Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.3 South America Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.4 South America Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.5 South America Gene Delivery Technologies Market: Country Analysis
• 16.6 Brazil Market
• 16.7 Brazil Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.8 Brazil Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.9 Brazil Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
  • 17.1.1 Market Overview
  • 17.1.2 Region Information
  • 17.1.3 Market Information
  • 17.1.4 Background Information
  • 17.1.5 Government Initiatives
  • 17.1.6 Regulations
  • 17.1.7 Regulatory Bodies
  • 17.1.8 Major Associations
  • 17.1.9 Taxes Levied
  • 17.1.10 Corporate Tax Structure
  • 17.1.11 Major Companies
• 17.2 Middle East Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.3 Middle East Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.4 Middle East Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

• 18.1 Summary
  • 18.1.1 Market Overview
  • 18.1.2 Region Information
  • 18.1.3 Market Information
  • 18.1.4 Background Information
  • 18.1.5 Government Initiatives
  • 18.1.6 Regulations
  • 18.1.7 Regulatory Bodies
  • 18.1.8 Major Associations
  • 18.1.9 Taxes Levied
  • 18.1.10 Corporate Tax Structure
  • 18.1.11 Major Companies
• 18.2 Africa Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.3 Africa Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.4 Africa Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

• 19.1 Company Profiles
• 19.2 Horizon Discovery Group Co
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Business Strategy
  • 19.2.4 Financial Overview
• 19.3 Bio-Rad Laboratories, Inc.
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Business Strategy
  • 19.3.4 Financial Overview
• 19.4 Promega Corporation
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Business Strategy
  • 19.4.4 Financial Overview
• 19.5 OriGene Technologies Inc.
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Business Strategy
  • 19.5.4 Financial Overview
• 19.6 Takara Bio Inc.
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
  • 19.6.3 Business Strategy
  • 19.6.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

• 22.1 Tectonic Therapeutic Merged With AVROBIO
• 22.2 Kyowa Kirin Acquired Orchard Therapeutics
• 22.3 Syncona Acquired Applied Genetic Technologies Corp.
• 22.4 Eli Lilly Acquired Akouos
• 22.5 Eli Lilly Acquired Prevail Therapeutics

23 Opportunities And Strategies

• 23.1 Global Gene Delivery Technologies Market In 2028 - Countries Offering Most New Opportunities
• 23.2 Global Gene Delivery Technologies Market In 2028 - Segments Offering Most New Opportunities
• 23.3 Global Gene Delivery Technologies Market In 2028 - Growth Strategies
  • 23.3.1 Market Trend Based Strategies
  • 23.3.2 Competitor Strategies

24 Gene Delivery Technologies Market, Conclusions And Recommendations

• 24.1 Conclusions
• 24.2 Recommendations
  • 24.2.1 Product
  • 24.2.2 Place
  • 24.2.3 Price
  • 24.2.4 Promotion
  • 24.2.5 People

25 Appendix

• 25.1 Geographies Covered
• 25.2 Market Data Sources
• 25.3 Research Methodology
• 25.4 Currencies
• 25.5 The Business Research Company
• 25.6 Copyright and Disclaimer